{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:21:30Z","timestamp":1792419690029,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["no. 8157040652"],"award-info":[{"award-number":["no. 8157040652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["no. 81900552"],"award-info":[{"award-number":["no. 81900552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Risk stratification to identify patients with high risk of variceal rebleeding is particularly important in patients with decompensated cirrhosis. In clinical practice, eliminating gastroesphageal varices thoroughly after sequential endoscopic treatment reduces the rebleeding rate, however, no simple method has been build to predict high risk of variceal rebleeding. We conducted this study to explore the value of the number of endoscopic sessions required to eradicate gastroesphageal varices in identifying high risk of rebleeding.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>Consecutive cirrhotic patients received sequential endoscopic therapy between January 2015 and March 2020 were enrolled. Endoscopic treatment was performed every 1\u20134\u00a0weeks until the eradication of varices. The primary endpoint was variceal rebleeding.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 146 patients were included of which 60 patients received standard therapy and 86 patients underwent sequential endoscopic treatment alone. The cut-off value of the number of sequential endoscopic sessions is 3.5 times. Variceal rebleeding was significant higher in patients with endoscopic sessions\u2009&gt;\u20093 times versus \u2264\u20093 times (61.5% vs. 17.5%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Variceal rebleeding of patients with endoscopic sessions\u2009\u2264\u20093 times was significant lower than patients with &gt;\u20093 times in group of standard therapy (19.6% vs. 88.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and endoscopic therapy (15.9% vs. 47.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.028) respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The number of sequential endoscopic sessions required to eradicate the varices is related to the risk of variceal rebleeding in patients with cirrhosis. If three times of endoscopic treatment can not eradicate the varices, a more aggressive treatment such as TIPS should be seriously considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02283-0","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T03:03:57Z","timestamp":1651547037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Huiwen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangqiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"2283_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cld.2014.01.007","volume":"18","author":"A Albillos","year":"2014","unstructured":"Albillos A, Tejedor M. Secondary prophylaxis for esophageal variceal bleeding. Clin Liver Dis. 2014;18:359\u201370.","journal-title":"Clin Liver Dis"},{"key":"2283_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrgastro.2013.51","volume":"10","author":"J O'Brien","year":"2013","unstructured":"O\u2019Brien J, Triantos C, Burroughs AK. Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:402\u201312.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2283_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u201352.","journal-title":"J Hepatol"},{"key":"2283_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.mcg.0000225681.45088.48","volume":"42","author":"AT Wolf","year":"2008","unstructured":"Wolf AT, Maurer R, Glickman J, Grace ND. Hepatic venous pressure gradient supplements liver biopsy in the diagnosis of cirrhosis. J Clin Gastroenterol. 2008;42:199\u2013203.","journal-title":"J Clin Gastroenterol"},{"key":"2283_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254\u201361.","journal-title":"N Engl J Med"},{"key":"2283_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/gutjnl-2020-322367","volume":"70","author":"A Yamamoto","year":"2020","unstructured":"Yamamoto A, Kawada N, Jogo A, et al. Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein. Gut. 2020;70:1199\u2013201.","journal-title":"Gut"},{"key":"2283_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/jhep.2000.19322","volume":"32","author":"C Merkel","year":"2000","unstructured":"Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930\u20134.","journal-title":"Hepatology"},{"key":"2283_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","volume":"131","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611\u201324.","journal-title":"Gastroenterology"},{"key":"2283_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1053\/jhep.2003.50133","volume":"37","author":"JG Abraldes","year":"2003","unstructured":"Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003;37:902\u20138.","journal-title":"Hepatology"},{"key":"2283_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0016-5085(92)90185-2","volume":"102","author":"C Merkel","year":"1992","unstructured":"Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992;102:973\u20139.","journal-title":"Gastroenterology"},{"key":"2283_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","volume":"32","author":"A Zipprich","year":"2012","unstructured":"Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407\u201314.","journal-title":"Liver Int"},{"key":"2283_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310\u201335.","journal-title":"Hepatology"},{"key":"2283_CR13","unstructured":"Rios CE, Seron P, Gisbert JP, Bonfill CX. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database Syst Rev 2015D10180."},{"key":"2283_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/hep.20584","volume":"41","author":"J de la Pena","year":"2005","unstructured":"de la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41:572\u20138.","journal-title":"Hepatology"},{"key":"2283_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","volume":"64","author":"D Tripathi","year":"2015","unstructured":"Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680\u2013704.","journal-title":"Gut"},{"key":"2283_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.dld.2011.03.002","volume":"43","author":"C Merkel","year":"2011","unstructured":"Merkel C, Montagnese S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis. 2011;43:762\u20137.","journal-title":"Dig Liver Dis"},{"key":"2283_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"MBCV Paolo Angeli","year":"2018","unstructured":"Paolo Angeli MBCV. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u201360.","journal-title":"J Hepatol"},{"key":"2283_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2020.09.034","volume":"74","author":"H Wang","year":"2020","unstructured":"Wang H, Wen B, Chang X, et al. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. J Hepatol. 2020;74:584\u201392.","journal-title":"J Hepatol"},{"key":"2283_CR19","first-page":"3860390","volume":"2020","author":"H Zhu","year":"2020","unstructured":"Zhu H, Guo H, Yin X, et al. Spleen stiffness predicts survival after transjugular intrahepatic portosystemic shunt in cirrhotic patients. Biomed Res Int. 2020;2020:3860390.","journal-title":"Biomed Res Int"},{"key":"2283_CR20","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/hep.29612","volume":"67","author":"C Jansen","year":"2018","unstructured":"Jansen C, Moller P, Meyer C, et al. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 2018;67:1472\u201384.","journal-title":"Hepatology"},{"key":"2283_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-230X-10-5","volume":"10","author":"F Petrasch","year":"2010","unstructured":"Petrasch F, Grothaus J, Mossner J, Schiefke I, Hoffmeister A. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol. 2010;10:5.","journal-title":"BMC Gastroenterol"},{"key":"2283_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.28597","volume":"64","author":"S Sheibani","year":"2016","unstructured":"Sheibani S, Khemichian S, Kim JJ, et al. Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology. 2016;64:549\u201355.","journal-title":"Hepatology"},{"key":"2283_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.28318","volume":"63","author":"IL Holster","year":"2016","unstructured":"Holster IL, Tjwa ET, Moelker A, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding. Hepatology. 2016;63:581\u20139.","journal-title":"Hepatology"},{"key":"2283_CR24","first-page":"630","volume":"51","author":"M Deschenes","year":"2000","unstructured":"Deschenes M, Barkun AN. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. Gastrointest Endosc. 2000;51:630\u20133.","journal-title":"Gastrointest Endosc"},{"key":"2283_CR25","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3748\/wjg.v17.i28.3347","volume":"17","author":"L Xu","year":"2011","unstructured":"Xu L, Ji F, Xu QW, Zhang MQ. Risk factors for predicting early variceal rebleeding after endoscopic variceal ligation. World J Gastroenterol. 2011;17:3347\u201352.","journal-title":"World J Gastroenterol"},{"key":"2283_CR26","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1136\/gut.2009.195321","volume":"59","author":"RS Kumarasena","year":"2010","unstructured":"Kumarasena RS, Niriella MA, Kalubowila U, de Silva AP, Dassanayake AS, de Silva HJ. Bleeding from oesophageal ulceration induced by endoscopic variceal ligation for primary prophylaxis. Gut. 2010;59:1586.","journal-title":"Gut"},{"key":"2283_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/j.1365-2036.2012.05074.x","volume":"35","author":"M Thiele","year":"2012","unstructured":"Thiele M, Krag A, Rohde U, Gluud LL. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Aliment Pharmacol Ther. 2012;35:1155\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"2283_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2036.2009.04075.x","volume":"30","author":"J Cheung","year":"2009","unstructured":"Cheung J, Zeman M, van Zanten SV, Tandon P. Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices. Aliment Pharmacol Ther. 2009;30:577\u201388.","journal-title":"Aliment Pharmacol Ther"},{"key":"2283_CR29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","volume":"361","author":"J Bosch","year":"2003","unstructured":"Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361:952\u20134.","journal-title":"Lancet"},{"key":"2283_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1440-1746.2009.05792.x","volume":"24","author":"GH Lo","year":"2009","unstructured":"Lo GH, Chen WC, Chan HH, et al. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol. 2009;24:982\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"2283_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/gut.2008.171207","volume":"58","author":"JC Garcia-Pagan","year":"2009","unstructured":"Garcia-Pagan JC, Villanueva C, Albillos A, et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. Gut. 2009;58:1144\u201350.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02283-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T03:04:01Z","timestamp":1651547041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02283-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02283-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol, which conformed to the principles of the 1975 Declaration of Helsinki, was approved by the Ethics Committee of our center. Informed consent was obtained from all patients included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for our study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}